BioVoice News to organize e-Conference on ‘Digital Laboratories: The Emerging Era of High-Tech R&D’ on March 30

This e-Conference on March 30, 2022 from 3:00 PM - 4:30 PM IST aims to highlight fresh insights on the digitally powered smart labs for the awareness of the stakeholders in biopharmaceutical R&D ecosystem

0
332
New Delhi: BioVoice News, India’s leading digital news media platform for providing news and insights on the life sciences industry, is organizing an E-conference on “Digital Laboratories: The Emerging Era of High-Tech R&D” on Wednesday, March 30, 2022 from 3:00 PM – 4:30 PM IST.
Among the confirmed speakers are Dr Anil Koul, Vice President-Global Public Health Discovery, Johnson & Johnson; Dr Anu Singh, Chief Scientific Officer, Dabur; Dr Prabuddha Kundu, Managing Director, Premas Biotech; Dr VL Ramaprasad, CEO, MedGenome; Dr Taslimarif Sayied, Director & CEO, C-CAMP; and Nicholas Tan, Head-South East Asia, Illumina. The virtual event will be moderated by Rahul Koul, Chief Editor, BioVoice News.
Discussion points include Understanding the concept and scope of digital labs; Lessons from Covid-19: Acceleration of R&D; Connected Labs & advanced automation for better outcomes; New era of digital lab equipment; Digital Labs: Catalyst for Make in India; and Industry and academia perspectives
Here’s the link to register for attending the live session on Wednesday, March 30, 2022 from 3:00 PM – 4:30 PM IST.
The virtual event is highly relevant for biotech and biopharma industry; R&D Scientists; Research Associates; Lab Technicians; Academia-Research Institutes & Universities; Technology Providers; and Students.
Sharing the objective behind the e-Conference, Rahul Koul, Chief Editor, BioVoice News said, “Digital technology could play a huge role in helping companies to optimize their R&D outcomes. New digital technologies like blockchain and predictive analytics can be readily integrated with existing Internet of Things (IoT) infrastructure to create smart labs. This e-Conference aims to highlight fresh insights on the digitally powered smart labs for the awareness of the stakeholders in biotech & biopharmaceutical R&D ecosystem.”
As technologies improve, the biotechnology and pharmaceutical companies are using the facilities ranging from smart sensors, artificial intelligence (AI) and other advanced options to streamline existing processes or pursue innovations. Ongoing research suggests using big data and AI could be a game-changing strategy for finding new drugs and increasing their chances of regulatory success. There’s a growing interest in using intelligent analytics tools to help make sense of the massive quantities of data collected in biotech and similar fields.
By switching to a digital lab, organizations can take one step towards being more productive and help to prevent research delays due to missing access to needed info. Automation will make it easier for lab managers to focus on more specialized tasks and responsibilities. It doesn’t just eliminate human error but also helps scientists spend their valuable time and energy in the right direction and be more productive.